Safety, Pharmacokinetics and Pharmacodynamics Study of BMS-866949 in Healthy Subjects

NCT00949767 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Depression

Interventions

DRUG: BMS-866949
DRUG: BMS-866949
DRUG: BMS-866949
DRUG: BMS-866949
DRUG: BMS-866949
DRUG: BMS-866949
DRUG: BMS-866949
DRUG: Placebo

Sponsor

Bristol-Myers Squibb